The Current Ratio as of November 2024 (TTM) for Absci Corporation (ABSI) is 5.63

According to Absci Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 5.63. This represents a change of -3.75% compared to the average of 5.85 of the last 4 quarters.

Absci Corporation (ABSI) Historical Current Ratio (quarterly & annually)

How has ABSI Current Ratio performed in the past?

The mean historical Current Ratio of Absci Corporation over the last ten years is 5.90. The current 5.63 Current Ratio has changed 9.43% with respect to the historical average. Over the past ten years (40 quarters), ABSI's Current Ratio was at its highest in in the March 2021 quarter at 10.66. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Absci Corporation (ABSI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Absci Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Absci Corporation (ABSI) Average Current Ratio

How has ABSI Current Ratio performed in the past?

The current Current Ratio of Absci Corporation (ABSI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Absci Corporation (ABSI) Current Ratio vs. Peers

How is ABSI’s Current Ratio compared to its peers?

Absci Corporation’s Current Ratio is greater than Recursion Pharmaceuticals, Inc. (4.35), greater than Affimed N.V. (1.93), greater than Sana Biotechnology, Inc. (4.47), less than Relay Therapeutics, Inc. (18.42), greater than Exscientia plc (4.54), less than VectivBio Holding AG (9.14), less than Zura Bio Limited (10.36), less than Elevation Oncology, Inc. (17.77), less than Icosavax, Inc. (18.06), less than AVROBIO, Inc. (26.17), greater than Hepion Pharmaceuticals, Inc. (1.30), less than Precision BioSciences, Inc. (9.22), less than Caribou Biosciences, Inc. (7.38), greater than ContraFect Corporation (0.53), less than Graphite Bio, Inc. (11.47), less than Day One Biopharmaceuticals, Inc. (14.62), less than Acumen Pharmaceuticals, Inc. (10.43), greater than X4 Pharmaceuticals, Inc. (4.89), less than Inozyme Pharma, Inc. (7.68),

Build a custom stock screener for Absci Corporation (ABSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Absci Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Absci Corporation (ABSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Absci Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.